Committee Composition

  Audit Compensation and Management Development Nominating and Corporate Governance
Lewis T. "Rusty" Williams, M.D., Ph.D. Chairman of the Board      
Lewis Williams Founder, President and CEO

Dr. Williams founded the company in December 2001 and has served as a member of our board of directors since January 2002, as our President and Chief Executive Officer since August 2011, and as our Executive Chairman from July 2003 to January 2012. Previously, Dr. Williams spent seven years at Chiron Corporation, a biopharmaceutical company, now Novartis Vaccines and Diagnostics, Inc., most recently as its Chief Scientific Officer. He also served on Chiron’s board of directors from 1999 to 2001. Prior to joining Chiron, Dr. Williams was a professor of medicine at the University of California, San Francisco and served as director of the University’s Cardiovascular Research Institution and Daiichi Research Center. Dr. Williams also has served on the faculties of Harvard Medical School and Massachusetts General Hospital and co-founded COR Therapeutics, Inc., a biotechnology company focused on cardiovascular disease. He is a member of the National Academy of Sciences and a fellow of the American Academy of Arts and Sciences. Dr. Williams was previously a member of the boards of directors of COR Therapeutics, Inc. and Beckman Coulter, Inc., each of which is a public company. Dr. Williams received a B.S. from Rice University and an M.D. and a Ph.D. from Duke University.


Franklin M. Berger, CFA Committee Chair for Audit Committee   Member of Nominating and Corporate Governance Committee
Garry Nicholson Member of Audit Committee    
Sheila Gujrathi, M.D.   Committee Chair for Compensation and Management Development Committee  
Peder K. Jensen, M.D.   Member of Compensation and Management Development Committee Committee Chair for Nominating and Corporate Governance Committee
Mark D. McDade   Member of Compensation and Management Development Committee  
William R. Ringo Member of Audit Committee   Member of Nominating and Corporate Governance Committee
Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member

FPRX (Common Stock)

Exchange
NASDAQ
Price
28.06
Change (%)
-0.44
Volume
333,976

Data as of 4:00 PM ET on Friday, August 18, 2017
Minimum 20 minute delay
Refresh quote
Powered By eSignal, Inc.